Q32 Bio (QTTB) Equity Average (2018 - 2025)
Historic Equity Average for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$15.3 million.
- Q32 Bio's Equity Average fell 15922.67% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.3 million, marking a year-over-year decrease of 15922.67%. This contributed to the annual value of -$88.6 million for FY2024, which is 348579.81% down from last year.
- Per Q32 Bio's latest filing, its Equity Average stood at -$15.3 million for Q3 2025, which was down 15922.67% from -$8.1 million recorded in Q2 2025.
- Q32 Bio's 5-year Equity Average high stood at $253.3 million for Q2 2022, and its period low was -$169.7 million during Q4 2023.
- Its 5-year average for Equity Average is $65.6 million, with a median of $25.9 million in 2024.
- Data for Q32 Bio's Equity Average shows a peak YoY increase of 12938.99% (in 2024) and a maximum YoY decrease of 42929.63% (in 2024) over the last 5 years.
- Q32 Bio's Equity Average (Quarter) stood at $184.1 million in 2021, then grew by 5.11% to $193.5 million in 2022, then crashed by 187.68% to -$169.7 million in 2023, then skyrocketed by 107.06% to $12.0 million in 2024, then plummeted by 228.01% to -$15.3 million in 2025.
- Its Equity Average was -$15.3 million in Q3 2025, compared to -$8.1 million in Q2 2025 and $830500.0 in Q1 2025.